Care-by-parent model as a tool for reduction of neonatal opioid withdrawal syndrome in neonates exposed to buprenorphine maintenance therapy in-utero

Megan L. Lawlor, Lori A. Shook, Kristen McQuerry, Aarthi Srinivasan, Quinetta B. Johnson, Niraj R. Chavan, Agatha S. Critchfield

Research output: Contribution to journalArticlepeer-review

3 Scopus citations

Abstract

Objective: To determine if a structured care-by-parent (CBP) protocol is associated with a reduction in diagnosis of treatment-requiring Neonatal Opioid Withdrawal Syndrome (NOWS). Study design: We performed a pilot retrospective, case control study of pregnant women enrolled in a comprehensive prenatal care program for opioid-dependent patients during which they received buprenorphine for Medication Assisted Treatment (MAT) for Opioid Use Disorder (OUD). Patients who participated in the CBP program actively roomed-in with their infants even after maternal hospital discharge while infants continued to be monitored for development of treatment-requiring NOWS. The primary outcome was the rate of treatment-requiring NOWS in the CBP grouping. Results: Thirty-two (32) cases that were enrolled in the CBP model were compared with 32 matched controls that were not enrolled in this model. There was a significant reduction in the rate of treatment-requiring NOWS among cases compared to the controls (OR = 0.10; p =.001). Neonates undergoing CBP had a decreased length of stay and lower Finnegan scores compared to those who did not undergo CBP Conclusion: Among infants born to mothers with OUD in pregnancy, CBP significantly reduces the rate of treatment-requiring NOWS.

Original languageEnglish
Pages (from-to)2718-2722
Number of pages5
JournalJournal of Maternal-Fetal and Neonatal Medicine
Volume33
Issue number16
DOIs
StatePublished - Aug 17 2020

Keywords

  • Buprenorphine
  • care by parent
  • medication assisted treatment
  • neonatal opioid withdrawal syndrome
  • opioid use disorder

Fingerprint

Dive into the research topics of 'Care-by-parent model as a tool for reduction of neonatal opioid withdrawal syndrome in neonates exposed to buprenorphine maintenance therapy in-utero'. Together they form a unique fingerprint.

Cite this